Summarized by Masters of Longevity from Lifespan.io.
Conference reports AI-discovered and GLP-1 drug effects on aging biomarkers.
Key Takeaways
- Insilico showed proteomic and arterial-clock shifts from rentosertib.
- Eli Lilly reported tirzepatide altered multiple biological age clocks.
- Mouse and small human trials were reported but remain preliminary.
